J Korean Ophthalmol Soc.  2021 Dec;62(12):1663-1666. 10.3341/jkos.2021.62.12.1663.

Ocular and Facial Herpes Zoster and Meningitis in an Adult after Zoster Vaccination

• Choi JH
• Ahn M
• Cho NC
• You IC

• KMID: 2523321
• DOI: http://doi.org/10.3341/jkos.2021.62.12.1663

Abstract

Purpose
To report a case of ocular and facial herpes zoster and meningitis after herpes zoster vaccination.
Case summary
A 60-year-old man was administered Zostavax^® on his left arm; he developed a vesicular rash over his left eye and forehead 4 days afterwards. He started antiviral drugs for the rash, and visited the hospital for severe headache and spread of the rash to involve the tip of his nose, face, and palate by day 7. He was taking Synthyroid^® (Bukwang Pharmaceuticals, Seoul, Korea) since his thyroidectomy for thyroid cancer 6 years ago. He had never been diagnosed with chickenpox, but had an episode of red facial rash in childhood. Slit-lamp examination revealed conjunctival chemosis, hyperemia, and a pseudodendrite in the peripheral cornea. The anterior chamber was quiet, and there were no significant findings on his brain magnetic resonance imaging. Varicella zoster virus was detected in the cerebrospinal fluid by polymerase chain reaction. The patient was treated with oral acyclovir drugs and topical ganciclovir, levofloxacin, and bromfenac. One week later, the pseudodendrite disappeared and conjunctival chemosis improved. There was no recurrence during 6 months follow-up.
Conclusions
Reactivation of ocular or facial herpes zoster or meningitis after zoster vaccination may occur, rarely. Immediate antiviral treatment is required in these cases.

Keyword

Herpes zoster ophthalmicus, Herpes zoster vaccine, Meningitis, Zostavax